Tag
President Trump signed an executive order to accelerate federal access to psychedelic drug treatments, with Health Secretary RFK Jr. backing ibogaine as an alternative for depression and mental health conditions. The move challenges existing Schedule I restrictions and puts the FDA and DEA on notice to adapt clinical
President Trump signed an executive order directing the FDA to expedite psychedelic drug access through breakthrough designation and right-to-try pathways. FDA Commissioner Marty Makary said three priority review vouchers for serotonin 2a agonists will be issued next week, with broader agency decisions expected this
Tag
President Trump signed an executive order to accelerate federal access to psychedelic drug treatments, with Health Secretary RFK Jr. backing ibogaine as an alternative for depression and mental health conditions. The move challenges existing Schedule I restrictions and puts the FDA and DEA on notice to adapt clinical
2mo ago · 1 min · Policy & Government
President Trump signed an executive order directing the FDA to expedite psychedelic drug access through breakthrough designation and right-to-try pathways. FDA Commissioner Marty Makary said three priority review vouchers for serotonin 2a agonists will be issued next week, with broader agency decisions expected this
2mo ago · 1 min · Policy & Government
— End of feed —